Tempus AI price target raised to $60 from $54 at BofA
BofA raised the firm’s price target on Tempus AI (TEM) to $60 from $54 and keeps a Neutral rating on the shares after the company reported Q4 ...
Bank of America Securities Keeps Their Hold Rating on Tempus AI, Inc. Class A (TEM)
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research ...
Investor's Business Daily on MSN2h
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
AbbVie inked a licensing deal Monday worth up to $2.23 billion for an amylin-targeting obesity treatment from Denmark-based ...
Microsoft22h
Build the future of your business with AI
Microsoft helps you scale AI confidently across your organization, wherever you are in your AI journey. Achieve new productivity levels and learn how to securely integrate AI for all your business ...